Finsen Technologies Limited in London, EC4M 7RD

Description

Data updated on: 01-11-2023

Finsen Technologies came into being in 2012 as a company enlisted under no 08260223, located at EC4M 7RD London at First Floor. The company has been in business for twelve years and its official state is active. The business name of the company got changed in the year 2015 to Finsen Technologies Limited. This enterprise former business name was Nanoclave. The company's registered with SIC code 86900: Other human health activities. Its latest filed accounts documents describe the period up to 2022-03-31 and the most current confirmation statement was filed on 2023-10-19.

There seems to be a team of four directors supervising the firm at the moment, specifically Tristan W., Bill P., Stuart L. and Adam F. who have been utilizing the directors responsibilities since 1st January 2022. In addition, the managing director's assignments are regularly aided with by a secretary - Stephen B., who was chosen by this firm in April 2020.

Previous company's names
Finsen Technologies Limited 2015-01-29
Nanoclave Limited 2012-10-19

Financial data based on annual reports

Profit & Loss
Date of Accounts	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
Currency

Balance Sheet
Cash Bank On Hand	1 841	122 528	853 455	129 140	276 748
Current Assets	231 790	908 448	1 746 486	1 089 695	782 533
Debtors	77 704	670 111	306 899	599 907	137 111
Net Assets Liabilities	-407 538	-183 582	2 127 640	1 564 332	1 281 043
Other Debtors	74 083	259 368	91 771	39 850	28 008
Property Plant Equipment			58 892	47 273	56 079
Total Inventories	152 245	115 809	586 132	360 648

Other Financial Data
Accumulated Depreciation Impairment Property Plant Equipment	2 675		6 634	21 474	75 129
Amounts Owed By Related Parties				160 000
Amounts Owed To Group Undertakings	341 707	335 955			2 645
Average Number Employees During Period	7	7	10	11	5
Capital Reduction Decrease In Equity			249 920
Corporation Tax Recoverable		14 968	34 510	70 443	25 283
Creditors	631 336	1 578 822	19 757	13 607	6 764
Deferred Tax Asset Debtors			89 100	171 200
Fixed Assets			808 892	797 273	806 079
Increase From Depreciation Charge For Year Property Plant Equipment				14 840	53 655
Investments Fixed Assets	8	500 000	750 000	750 000	750 000
Investments In Group Undertakings Participating Interests	8	500 000		750 000	750 000
Issue Equity Instruments	1		1 899 265
Net Current Assets Liabilities	-399 546	-670 374	1 374 420	787 183	486 228
Number Equity Instruments Exercisable Share-based Payment Arrangement			867	732
Number Equity Instruments Granted Share-based Payment Arrangement			2 832	10
Number Equity Instruments Outstanding Share-based Payment Arrangement			2 832	1 729
Other Creditors	205 698	877 127	19 757	13 607	6 764
Other Taxation Social Security Payable			16 862	10 435	480
Profit Loss	-210 136	223 956	575 781	-658 440	-303 930
Property Plant Equipment Gross Cost	2 675		65 526	68 747	131 208
Provisions For Liabilities Balance Sheet Subtotal	8 000	13 208	35 915	6 517	4 500
Total Additions Including From Business Combinations Property Plant Equipment				3 221	62 461
Total Assets Less Current Liabilities	-399 538	-170 374	2 183 312	1 584 456	1 292 307
Trade Creditors Trade Payables	83 931	365 740	197 225	144 980	56 006
Trade Debtors Trade Receivables	3 621	395 775	91 518	158 414	83 820
Transfers To From Retained Earnings Increase Decrease In Equity				110 881	82 792
Weighted Average Exercise Price Equity Instruments Exercisable Share-based Payment Arrangement			1	5	6
Weighted Average Exercise Price Equity Instruments Exercised Share-based Payment Arrangement				11	0
Weighted Average Exercise Price Equity Instruments Forfeited Share-based Payment Arrangement					50
Weighted Average Exercise Price Equity Instruments Granted Share-based Payment Arrangement			2	50	0
Weighted Average Exercise Price Equity Instruments Outstanding Share-based Payment Arrangement			2	4	6